← Browse by Condition
Medical Condition
cardiomyopathy dilated
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT06091475
Recruiting
Therapy to Maintain Remission in Dilated Cardiomyopathy
Enrollment
50 pts
Location
United Kingdom
Sponsor
Imperial College London
NCT05321875 Phase 3
Recruiting
Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)
Enrollment
320 pts
Location
Spain
Sponsor
Cristina Avendaño Solá